Tsai-Ta Lai
Co-founder, Executive Chairman & CEODr. Tsai-Ta Lai, also known as Chris, is Co-founder of Metis Techbio Co., LTD and has been its Chief Executive Officer since February 12, 2020. Dr. Lai is the Chairman of the Board of Metis Techbio Co. LTD since October 2, 2019 and has been its Executive Director from August 2025. Dr. Lai joined the Metis Techbio Co. LTD on October 2, 2019. He is responsible for the overall management of business strategies, R&D, operation and financing of Group. Dr. Lai serves as a director in certain of its subsidiaries of Company including Beijing Jitai, Shanghai Jitai, Suzhou Jitai, Shanghai Metis, Metis HK, Metis Australia, Metis Therapeutics. Dr. Lai has extensive work experience in the technology industry and consulting industry. Prior to joining Metis Techbio, Dr. Lai served as a chief technology officer of AquaFresco Inc. from June 2016 to June 2017, where he was primarily responsible for the technology development of the company. Dr. Lai served as an associate of McKinsey & Company from July 2017 to July 2019, where he was primarily responsible for providing strategic advisory services. Dr. Lai also served as the head of science and technology strategy and enterprise development of the Boston Branch of XtalPi Holdings Limited, where he was primarily responsible for providing strategic advisory services. Dr. Lai received his bachelor’s degree in chemical engineering from Taiwan University in June 2011. He received his master’s degree and doctorate degree in chemical engineering from Massachusetts Institute of Technology in the United States in June 2014 and June 2016, respectively.
Positions
- Company NameMetis TechBio Co., Ltd.Stock Code07666PositionCo-founder, Executive Chairman & CEOColleagues
